[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Databases::
Editorial Board::
Executive Members::
Instruction to Authors::
Peer Review::
Articles Archive::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 20, Issue 3 (10-2018) ::
J Gorgan Univ Med Sci 2018, 20(3): 99-103 Back to browse issues page
Frequency of anti neutrophil cytoplasmic antibody (ANCA) in patient with systemic lupus erythematus and its association with disease activity
Navid Rahimi1 , Nafiseh Abdolahi2 , Sima Sedighi3 , Mehrdad Aghae4 , Atefeh Rezaeifar *5
1- (First Author) Medical Student, Student Research Committee, Golestan University of Medical Sciences, Gorgan, Iran
2- (First Author) Assistant Professor, Rheumatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran
3- Rheumatologist, Rheumatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran
4- Associate Professor, Rheumatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran
5- Internist, Clinical Research Development Unit, Sayyad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran. atefehrezaeifar@yahoo.co.uk , atefehrezaeifar@yahoo.co.uk
Abstract:   (8623 Views)
Background and Objective: Systemic lupus erythatous (SLE) is an autoimmune disease with clinical symptoms. Anti neutrophil cytoplasmic antibody (ANCA) is common in vasculitis which is reported in SLE. This study was done to determine the frequency of ANCA in patient with SLE and its association with disease activity.
Methods: This descriotive study was conducted on 80 patients with SLE whom referred to rheumatology clinic in Gorgan, northern Iran during 2012-15. The patients disorder diagnosed based on the ACR Criteria. According to the disease activity the patients divided to active group and inactive group. Demographic data was completed with questionnaire and blood sample collected in order to evaluate of for serum ANCA by using ELISA method.
Results: The average age was 37.5±12.4 year. Seven (8.5%) patients were males. 91.5% of patients was females. 27 patients (33%) had active lupus and 53 (57%) had inactive lupus. Only one patient has been reported as positive for ANCA. The patient was a 45 years woman with history of 10 years of lupus nephritis with active disease.
Conclusion: There was no relationship between ANCA and disease activity. The main reason for this finding can be a few numbers of positive cases in this study.
Keywords: Systemic lupus erythatous, Anti neutrophil cytoplasmic antibody, Disease activity
Full-Text [PDF 225 kb] [English Abstract]   (22755 Downloads) |   |   Abstract (HTML)  (594 Views)  
Type of Study: Original Articles | Subject: Internal Medicine
* Corresponding Author Address: Internist, Clinical Research Development Unit, Sayyad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran. atefehrezaeifar@yahoo.co.uk
References
1. Waldendorf M, Schneider M. Anti-neutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus. Adv Exp Med Biol. 1993; 336: 381-84.
2. Falk RJ, Merkel PA. Clinical spectrum of antineutrophil cytoplasmic autoantibodies. Waltham, MA: UpToDate. 2016.
3. Pan HF, Fang XH, Wu GC, Li WX, Zhao XF, Li XP, et al. Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus and lupus nephritis. Inflammation. 2008 Aug; 31(4): 260-65. doi:10.1007/s10753-008-9073-3
4. Nässberger L, Jonsson H, Sjöholm AG, Sturfelt G, Heubner A. Circulating anti-elastase in systemic lupus erythematosus. Lancet. 1989 Mar; 1(8636): 509.
5. Pauzner R, Urowitz M, Gladman D, Gough J. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. J Rheumatol. 1994 Sep; 21(9): 1670-73.
6. Fauzi AR, Kong NC, Chua MK, Jeyabalan V, Idris MN, Azizah R. Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations. Med J Malaysia. 2004 Aug; 59(3): 372-77.
7. Nishiya K, Chikazawa H, Nishimura S, Hisakawa N, Hashimoto K. Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features. Clin Rheumatol. 1997 Jan; 16(1): 70-75.
8. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov; 25(11): 1271-77.
9. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 Sep; 40(9): 1725. doi:10.1002/1529-0131(199709)40:9
10. Sobral S, Ramassur K, Apsley E, Isenberg D. Do anti-neutrophil cytoplasmic antibodies play a role in systemic lupus erythematosus (SLE) patients? Analysis of the University College Hospital SLE cohort. Lupus. 2018 Feb; 27(2): 343-44. doi:10.1177/0961203317724218
11. Su F, Xiao W,Yang P, Chen Q, Sun X, Li T. Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus. An Bras Dermatol. 2017; 92(4): 446-49. http://dx.doi.org/10.1590/abd1806-4841.20175476
12. Li C, Zhou ML, Liang DD, Wang JJ, Yang J, Zeng CH, et al. Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study. BMJ Open. 2017 Jul; 7(7): e015668. doi:10.1136/bmjopen-2016-015668
13. Neves M, Irlapati RVP, Isenberg DA. Does the presence of ANCA in patients with lupus nephritis (LN) help to distinguish a subset? Annals of the Rheumatic Disease. 2014; 73(2): 983. doi:10.1136/annrheumdis-2014-eular.1606
14. Schnabel A, Csernok E, Isenberg DA, Mrowka C, Gross WL. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance. Arthritis Rheum. 1995 May; 38(5): 633-37.
15. Spronk PE, Bootsma H, Horst G, Huitema MG, Limburg PC, Tervaert JW, et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Br J Rheumatol. 1996 Jul; 35(7): 625-31.
16. Chin HJ, Ahn C, Lim CS, Chung HK, Lee JG, Song YW, et al. Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol. 2000 Jan-Feb; 20(1): 57-63. doi:10.1159/000013557
17. Amer AK, el-Behairy HF, Elsawy DH, Almalt MA, Kassem TM, Khalifa NM. Assessment of anti-neutrophil cytoplasmic antibodies and selected serum pro-inflammatory cytokines in systemic lupus erythematosus: prevalence and clinical significance. Egypt J Immunol. 2003; 10(2): 91-99.
18. Zhan X, Liu Q, Fan L, Hong L, Zhou Q, Chen W, et al. Clinicopathological characteristics and outcomes of patients with ANCA-positive lupus nephritis: a large cohort study from a single Chinese center. Int J Clin Exp Pathol. 2016; 9(2): 1819-28.
19. Almutlaq A, Urowitz M, Su J, Gladman DD. Antineurophil cytoplasmic Antibodies in Systemic Lupus Erythematosus; Incidence ,outcome and Prognosis. 2016 ACR/ARHP Annual meeting. Abstract Number: 2845.
20. Wang Y, Huang X, Cai J, Xie L, Wang W, Tang S, et al. Clinicopathologic Characteristics and Outcomes of Lupus Nephritis With Antineutrophil Cytoplasmic Antibody: A Retrospective Study. Medicine (Baltimore). 2016 Jan; 95(4): e2580. doi:10.1097/MD.0000000000002580
21. Turner-Stokes T, Wilson HR, Morreale M, Nunes A, Cairns T, Cook HT, et al. Positive antineutrophil cytoplasmic antibody serology in patients with lupus nephritis is associated with distinct histopathologic features on renal biopsy. Kidney Int. 2017 Nov; 92(5): 1223-31. doi:10.1016/j.kint.2017.04.029
Send email to the article author


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rahimi N, Abdolahi N, Sedighi S, Aghae M, Rezaeifar A. Frequency of anti neutrophil cytoplasmic antibody (ANCA) in patient with systemic lupus erythematus and its association with disease activity. J Gorgan Univ Med Sci 2018; 20 (3) :99-103
URL: http://goums.ac.ir/journal/article-1-3459-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 20, Issue 3 (10-2018) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 2.2 seconds with 34 queries by YEKTAWEB 4741
Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)